Jolien Veraart

Psychiatrist and PhD researcher at the University Medical Center Groningen / University of Groningen

Data updated

Papers

9 publications

Trials

0 clinical trials

Links

Research Footprint

Jolien Veraart appears in 9 tracked papers (2020–2025), most studied alongside Ketamine, Esketamine and Psilocybin, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Anxiety Disorders.

Most-cited paper: Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability (158 citations).

Frequent co-authors: Robert Schoevers, Jeanine Kamphuis and Sanne Smith-Apeldoorn.

Background & Research

Jolien K. E. Veraart is a psychiatrist and PhD researcher in the Department of Psychiatry at the University Medical Center Groningen and the University of Groningen, with an affiliated clinical role at PsyQ Haaglanden in The Hague. Her work focuses on ketamine and oral esketamine for treatment-resistant depression, including systematic reviews, clinical trials, and pharmacology. She is also involved in research on psychedelics in psychiatry and patient experiences of esketamine treatment.

Affiliations

Institutions, companies, and organisations Jolien Veraart is associated with.